A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate
Background: Owing to its role in cancer, the phosphoinositide 3-kinase (PI3K)/Akt pathway is an attractive target for therapeutic intervention. We previously reported that the inhibition of Akt by inositol 1,3,4,5,6- pentakisphosphate (InsP5) results in anti-tumour properties. To further develop thi...
| Main Authors: | Falasca, Marco, Chiozzotto, D., Godage, H., Mazzoletti, M., Riley, A., Previdi, S., Potter, B., Broggini, M., Maffucci, T. |
|---|---|
| Format: | Journal Article |
| Published: |
Nature Publishing Group
2010
|
| Online Access: | http://hdl.handle.net/20.500.11937/23657 |
Similar Items
Anti-cancer activity of the bioactive compound inositol pentakisphosphate
by: Falasca, Marco
Published: (2009)
by: Falasca, Marco
Published: (2009)
Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy
by: Kaboli, Parham Jabbarzadeh, et al.
Published: (2021)
by: Kaboli, Parham Jabbarzadeh, et al.
Published: (2021)
Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway
by: Edling, C., et al.
Published: (2014)
by: Edling, C., et al.
Published: (2014)
PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells
by: Chen, J., et al.
Published: (2015)
by: Chen, J., et al.
Published: (2015)
Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development
by: Falasca, Marco
Published: (2011)
by: Falasca, Marco
Published: (2011)
Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
by: Singh, S., et al.
Published: (2015)
by: Singh, S., et al.
Published: (2015)
Rethinking phosphatidylinositol 3-monophosphate
by: Falasca, Marco, et al.
Published: (2009)
by: Falasca, Marco, et al.
Published: (2009)
Phosphoinositides signalling in cancer: Focus on PI3K and PLC
by: Raimondi, C., et al.
Published: (2012)
by: Raimondi, C., et al.
Published: (2012)
Regulation and cellular functions of class II phosphoinositide 3-kinases
by: Falasca, Marco, et al.
Published: (2012)
by: Falasca, Marco, et al.
Published: (2012)
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas
by: Geyer, Felipe C., et al.
Published: (2018)
by: Geyer, Felipe C., et al.
Published: (2018)
An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation
by: Smit, L., et al.
Published: (2015)
by: Smit, L., et al.
Published: (2015)
New insight into the intracellular roles of class II phosphoinositide 3-kinases
by: Maffucci, T., et al.
Published: (2014)
by: Maffucci, T., et al.
Published: (2014)
Regulation of phosphatidylinositol 3-kinase (PI3K/Akt) pathway in chicken and duck cells and its implications for influenza A virus pathogenesis
by: Kumar, Sanjeeva
Published: (2018)
by: Kumar, Sanjeeva
Published: (2018)
Discovery of novel antitumor nitric oxide-donating b-elemene hybrids through inhibiting the PI3K/Akt pathway
by: Chen, Jichao, et al.
Published: (2017)
by: Chen, Jichao, et al.
Published: (2017)
Vitamin D and Stimulates the PI3K-AKT signaling pathway in insulin resistant SK-N-SH neuronal cells
by: Zaulkffali, Amirah Salwani, et al.
Published: (2019)
by: Zaulkffali, Amirah Salwani, et al.
Published: (2019)
Phospholipase C?1 is required for metastasis development and progression
by: Sala, G., et al.
Published: (2008)
by: Sala, G., et al.
Published: (2008)
Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway
by: Castresana, Javier S., et al.
Published: (2017)
by: Castresana, Javier S., et al.
Published: (2017)
Akt/protein kinase B in skeletal muscle physiology and pathology
by: Wu, M., et al.
Published: (2011)
by: Wu, M., et al.
Published: (2011)
PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling
by: Braccini, L., et al.
Published: (2015)
by: Braccini, L., et al.
Published: (2015)
Gelsolin-mediated activation of PI3K/Akt pathway is crucial for hepatocyte growth factor-induced cell scattering in gastric carcinoma
by: Huang, B., et al.
Published: (2016)
by: Huang, B., et al.
Published: (2016)
Vitamins D and E stimulate the PI3K-AKT signalling pathway in insulin-resistant SK-N-SH neuronal cells
by: Zaulkffali, Amirah Salwani, et al.
Published: (2019)
by: Zaulkffali, Amirah Salwani, et al.
Published: (2019)
Comparison of the expression of PI3K/AKT pathway components in type 2 diabetic and non- diabetic human volunteers ex vivo
by: Khorami, Somayeh Alsadat Hosseini
Published: (2018)
by: Khorami, Somayeh Alsadat Hosseini
Published: (2018)
A Potential Effect of Cordycepin on the Feedback between Polyadenylation and PI3K/Akt/mTOR Signalling
by: Lawrence, Steven
Published: (2023)
by: Lawrence, Steven
Published: (2023)
Investigating the mechanisms of activation and action of phosphoinositide 3-kinase C2 alpha in pancreatic beta cells
by: Mazza, S., et al.
Published: (2013)
by: Mazza, S., et al.
Published: (2013)
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme
by: Sestito, S., et al.
Published: (2015)
by: Sestito, S., et al.
Published: (2015)
Effects of albumin–chlorogenic acid nanoparticles on apoptosis and PI3K/Akt/mTOR pathway inhibitory activity in MDA-MB-435s cells
by: Alzahrani, Badr, et al.
Published: (2023)
by: Alzahrani, Badr, et al.
Published: (2023)
A Small Molecule Inhibitor of PDK1/PLCy1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion.
by: Raimondi, C., et al.
Published: (2016)
by: Raimondi, C., et al.
Published: (2016)
Elucidation of the WNT & AKT/Phosphoinositide-3-Kinase Pathways in Colorectal Carcinoma
by: Khor, Tin Oo
Published: (2004)
by: Khor, Tin Oo
Published: (2004)
Novel roles for class II Phosphoinositide 3-Kinase C2ß in signalling pathways involved in prostate cancer cell invasion.
by: Mavrommati, I., et al.
Published: (2016)
by: Mavrommati, I., et al.
Published: (2016)
Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis
by: Tibolla, G., et al.
Published: (2013)
by: Tibolla, G., et al.
Published: (2013)
Tualang honey promotes apoptosis of the A549 lung adenocarcinoma cell line via modulation of PI3K/AKT signaling pathway-related proteins
by: Nazirah A,, et al.
Published: (2022)
by: Nazirah A,, et al.
Published: (2022)
Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways
by: Kannaiyan, R., et al.
Published: (2011)
by: Kannaiyan, R., et al.
Published: (2011)
Sodium alginate encapsulated iron oxide decorated with thymoquinone nanocomposite induces apoptosis in human breast cancer cells via PI3K-Akt-mTOR pathway
by: Alzahrani, Badr, et al.
Published: (2023)
by: Alzahrani, Badr, et al.
Published: (2023)
Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts
by: Falasca, Marco, et al.
Published: (2014)
by: Falasca, Marco, et al.
Published: (2014)
Analysis, regulation, and roles of endosomal phosphoinositides
by: Maffucci, T., et al.
Published: (2014)
by: Maffucci, T., et al.
Published: (2014)
Coordination studies of inositols with aluminium and related cations
by: Chokazinga, Davlin
Published: (2003)
by: Chokazinga, Davlin
Published: (2003)
Using the Cre/loxP recombination system to study the role of the PI3K/AKT signalling transduction pathway and the embryonic cellular origin of adult haematopoietic stem cells in the zebrafish
by: Jalali, Maryam
Published: (2013)
by: Jalali, Maryam
Published: (2013)
Investigational ABC transporter inhibitors
by: Falasca, Marco, et al.
Published: (2012)
by: Falasca, Marco, et al.
Published: (2012)
Nanocomposites of iron oxide, sodium alginate, and eugenol induce apoptosis via PI3K/Akt/mTOR signaling in Hep3 cells and in vivo hepatotoxicity in the zebrafish model
by: Elderdery, Abozer Y., et al.
Published: (2024)
by: Elderdery, Abozer Y., et al.
Published: (2024)
PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CAIX and VEGF, in human cancer cell lines.
by: Shafee, Norazizah, et al.
Published: (2009)
by: Shafee, Norazizah, et al.
Published: (2009)
Similar Items
-
Anti-cancer activity of the bioactive compound inositol pentakisphosphate
by: Falasca, Marco
Published: (2009) -
Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy
by: Kaboli, Parham Jabbarzadeh, et al.
Published: (2021) -
Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway
by: Edling, C., et al.
Published: (2014) -
PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells
by: Chen, J., et al.
Published: (2015) -
Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development
by: Falasca, Marco
Published: (2011)